Acute coronary syndrome (ACS) is a syndrome caused by acute myocardial ischaemia precipitated by atherosclerotic plaque rupture or erosion, with differing degrees of superimposed thrombosis, vascular constriction and coronary occlusion. The precipitating symptom that triggers the diagnostic and therapeutic cascade is chest pain but many patients especially women and those with diabetes can present with ACS with atypical pain or no pain at all. Ticagrelor is used as dual antiplatelet therapy to treat acute coronary syndrome.
Ticagrelor is a potent antiplatelet agent used in combination with low dose aspirin (12 months) to reduce the risk of further cardiovascular events in patients with acute ACS. It is used in patients with/without-ST-segment elevation myocardial infarction (N/STEMI) or in patients with unstable angina with additional conditions such as Age 60 years or above Previous…
